Related Experiment Videos
Testis-specific HMG-domain protein alters the responses of cells to cisplatin
Deborah B Zamble1, Yuji Mikata, Christina H Eng
1Department of Chemistry, Massachusetts Institute of Technology, Cambridge, MA 02139-4307, USA.
Abstract:
Cisplatin is an effective agent for the treatment of testicular cancer. In the present study with mouse testicular teratocarcinoma cell extracts, we observed a deficiency in nucleotide excision repair (NER) of a DNA probe bearing a cisplatin 1,2-d(GpG) intrastrand cross-link. In contrast, repair of the cisplatin 1,3-d(GpTpG) intrastrand cross-link was still active in these cell extracts. A current working hypothesis is that complexes of HMG-domain proteins with the major cisplatin 1,2-intrastrand cross-links could enhance cisplatin cytotoxicity by blocking repair of these lesions on the genome. The family of HMG-domain proteins include a testis-specific protein, tsHMG, which might account for the altered NER in testicular cells. To test this possibility, a human cervical carcinoma cell line (HeLa) was constructed which ectopically expressed tsHMG under the control of an inducible promoter. Microscopic examination of tsHMG expression and cisplatin-induced apoptosis on a cellular level revealed that the nuclear protein did indeed modulate the cytotoxic consequences of cisplatin treatment. Also, tsHMG enhanced transcription inhibition by cisplatin. These results reveal that an HMG-domain protein can affect cellular responses to cisplatin and may be relevant to the clinical observation that cancer cells in specific tissues are particularly sensitive to cisplatin.
Insights
Testicular cancer cells show reduced DNA repair for cisplatin damage, linked to a testis-specific protein (tsHMG). This protein enhances cisplatin
Area of Science:
- Molecular Biology
- Genetics
- Cancer Research
Background:
- Cisplatin is a key chemotherapy drug for testicular cancer.
- Testicular cancer cells exhibit unique responses to cisplatin treatment.
- Nucleotide excision repair (NER) is crucial for DNA damage repair.
Purpose of the Study:
- To investigate the role of HMG-domain proteins in cisplatin resistance in testicular cells.
- To determine if testis-specific HMG (tsHMG) influences DNA repair and cisplatin cytotoxicity.
- To explore the mechanism by which tsHMG affects cellular response to cisplatin.
Main Methods:
- Assessing DNA repair efficiency of cisplatin adducts in mouse testicular teratocarcinoma cell extracts.
- Developing a HeLa cell line with inducible expression of tsHMG.
- Analyzing cisplatin-induced apoptosis and transcription inhibition in tsHMG-expressing cells.
Main Results:
- Mouse testicular cell extracts showed deficient repair of 1,2-d(GpG) cisplatin adducts but not 1,3-d(GpTpG) adducts.
- Ectopic expression of tsHMG in HeLa cells modulated cisplatin-induced apoptosis.
- tsHMG expression enhanced cisplatin-mediated transcription inhibition.
Conclusions:
- HMG-domain proteins, specifically tsHMG, can influence cellular sensitivity to cisplatin.
- Altered DNA repair mechanisms involving tsHMG may contribute to cisplatin efficacy in specific cancers.
- These findings offer insights into tissue-specific responses to cisplatin chemotherapy.